Views & Analysis Manchester setting the pace in NHS move to outcomes-based de... The NHS is moving rapidly towards integrated care models – and outcomes-based deals with pharma will also play a role.
Views & Analysis Just unveiled, the next big idea for England’s NHS Trailblazing ‘Accountable Care Systems’ announced in England to integrate health and social care.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.